Xtant Medical Holdings, Inc. received a letter from NYSE Regulation notifying the Company
- Form
- 8-K
- Filed
- Importance
- Routine
- Accession
- 0001493152-19-008280
- Reports an exchange listing deficiency notice (3.01)
- Makes a Regulation FD disclosure (7.01)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.
- Hyperfine HYPR public float $44M, Jun 30, 2025
- Vivani Medical EYES public float $46M, Jun 30, 2025
- Vivos RDGL public float $48M, Jun 30, 2025
- Alpha Pro Tech APT public float $41M, Jun 30, 2025
- Nuo Therapeutics AURX public float $41M, Jun 30, 2025
